Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-24-000109 General Corporate
Debt relative to revenue 0th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.debt_to_revenue
52.69% · OPTIONAL · VALID
Capex intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.67% · OPTIONAL · VALID
Operating cash generation 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
35.97% · OPTIONAL · VALID
Revenue growth 5th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
34.07% · CORE · VALID
Gross margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
77.99% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-5.60% · CORE · VALID
R&D intensity 55th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
23.06% · OPTIONAL · VALID
SBC intensity 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
24.34% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 205.66%
Current 52.69%
Delta -152.96% Capex Intensity Increased
Previous 6.44%
Current 6.67%
Delta 0.23% Cash Generation Increased
Previous 31.35%
Current 35.97%
Delta 4.63% Growth Increased
Previous 32.09%
Current 34.07%
Delta 1.97% Margin Decreased
Previous 78.61%
Current 77.99%
Delta -0.62% Profitability Decreased
Previous -0.54%
Current -5.60%
Delta -5.06% R And D Intensity Increased
Previous 22.59%
Current 23.06%
Delta 0.47% Sbc Intensity Increased
Previous 20.47%
Current 24.34%
Delta 3.87% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.